BioStar Capital
BioStar Capital is a Michigan-based venture capital firm focused on transformative medical technologies, with a particular emphasis on cardiology. Founded by Dr. Louis A. Cannon, the firm brings together healthcare clinicians, executives, thought leaders, and financial professionals to identify and support early- and late-stage investments in medical devices and related technologies. BioStar Capital operates multiple investment funds and employs a disciplined, holistic investment approach to mitigate risk and advance cardiovascular innovations.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Michigan
Amplitude Vascular Systems
Series B in 2023
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease.
It was founded in 2020 and is based in Ann Arbor, Michigan.
Amplitude Vascular Systems
Series B in 2023
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease.
It was founded in 2020 and is based in Ann Arbor, Michigan.
Amplitude Vascular Systems
Venture Round in 2022
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease.
It was founded in 2020 and is based in Ann Arbor, Michigan.
Ablative Solutions
Series D in 2022
Founded in 2011 and headquartered in San Jose, California with an additional office in Kalamazoo, Michigan, Ablative Solutions is a medical device company specializing in the development of catheters for treating hypertension. Its flagship product, the Peregrine System, enables minimally invasive delivery of diagnostic and therapeutic agents into the perivascular space surrounding peripheral blood vessels.
Ablative Solutions
Series D in 2019
Founded in 2011 and headquartered in San Jose, California with an additional office in Kalamazoo, Michigan, Ablative Solutions is a medical device company specializing in the development of catheters for treating hypertension. Its flagship product, the Peregrine System, enables minimally invasive delivery of diagnostic and therapeutic agents into the perivascular space surrounding peripheral blood vessels.
Ablative Solutions
Series B in 2014
Founded in 2011 and headquartered in San Jose, California with an additional office in Kalamazoo, Michigan, Ablative Solutions is a medical device company specializing in the development of catheters for treating hypertension. Its flagship product, the Peregrine System, enables minimally invasive delivery of diagnostic and therapeutic agents into the perivascular space surrounding peripheral blood vessels.
Ablative Solutions
Series A in 2012
Founded in 2011 and headquartered in San Jose, California with an additional office in Kalamazoo, Michigan, Ablative Solutions is a medical device company specializing in the development of catheters for treating hypertension. Its flagship product, the Peregrine System, enables minimally invasive delivery of diagnostic and therapeutic agents into the perivascular space surrounding peripheral blood vessels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.